| Authors: |
Sirard JC; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Cayet D; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Fougeron D; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Soulard D; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Tabareau J; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Hot D; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS - Plateformes Lilloises de Biologie & Santé, F-59000 Lille, France., Barnier-Quer C; Vaccine Formulation Laboratory, University of Lausanne, CH-1066 Epalinges, Switzerland., Jakob V; Vaccine Formulation Laboratory, University of Lausanne, CH-1066 Epalinges, Switzerland., Collin N; Vaccine Formulation Laboratory, University of Lausanne, CH-1066 Epalinges, Switzerland; Vaccine Formulation Institute, CH-1228 Plan-les-Ouates, Switzerland., Mollenkopf HJ; Max Planck Institute for Infection Biology, D-10117 Berlin, Germany., Stockhofe-Zurwieden N; Wageningen Bioveterinary Research, Wageningen University & Research, NL-8221 Lelystad, the Netherlands., Van Maele L; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France. Electronic address: laurye.van-maele@inserm.fr. |
